157 related articles for article (PubMed ID: 32591642)
21. A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas.
Munshi M; Liu X; Kofides A; Tsakmaklis N; Guerrera ML; Hunter ZR; Palomba ML; Argyropoulos KV; Patterson CJ; Canning AG; Meid K; Gustine J; Branagan AR; Flynn CA; Sarosiek S; Castillo JJ; Wang J; Buhrlage SJ; Gray NS; Munshi NC; Anderson KC; Treon SP; Yang G
Blood Adv; 2022 Jun; 6(11):3332-3338. PubMed ID: 35255496
[TBL] [Abstract][Full Text] [Related]
22. Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.
Maegawa S; Chinen Y; Shimura Y; Tanba K; Takimoto T; Mizuno Y; Matsumura-Kimoto Y; Kuwahara-Ota S; Tsukamoto T; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
Exp Hematol; 2018 Mar; 59():72-81.e2. PubMed ID: 29287939
[TBL] [Abstract][Full Text] [Related]
23. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D
J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.
Poh AR; Love CG; Masson F; Preaudet A; Tsui C; Whitehead L; Monard S; Khakham Y; Burstroem L; Lessene G; Sieber O; Lowell C; Putoczki TL; O'Donoghue RJJ; Ernst M
Cancer Cell; 2017 Apr; 31(4):563-575.e5. PubMed ID: 28399411
[TBL] [Abstract][Full Text] [Related]
25. Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma.
Li XY; Geng LY; Zhou XX; Wei N; Fang XS; Li Y; Wang X
Leuk Lymphoma; 2017 Oct; 58(10):2460-2469. PubMed ID: 28278702
[TBL] [Abstract][Full Text] [Related]
26. Hck tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1.
Smolinska MJ; Page TH; Urbaniak AM; Mutch BE; Horwood NJ
J Immunol; 2011 Dec; 187(11):6043-51. PubMed ID: 22021612
[TBL] [Abstract][Full Text] [Related]
27. Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma.
Chiron D; Dousset C; Brosseau C; Touzeau C; Maïga S; Moreau P; Pellat-Deceunynck C; Le Gouill S; Amiot M
Oncotarget; 2015 Apr; 6(11):8750-9. PubMed ID: 25797245
[TBL] [Abstract][Full Text] [Related]
28. Suppression of autophagy and HCK signaling promotes PTGS2
Mei J; Zhou WJ; Zhu XY; Lu H; Wu K; Yang HL; Fu Q; Wei CY; Chang KK; Jin LP; Wang J; Wang YM; Li DJ; Li MQ
Autophagy; 2018; 14(8):1376-1397. PubMed ID: 29962266
[TBL] [Abstract][Full Text] [Related]
29. Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer.
Roseweir AK; Powell AGMT; Horstman SL; Inthagard J; Park JH; McMillan DC; Horgan PG; Edwards J
Cell Signal; 2019 Apr; 56():15-22. PubMed ID: 30684564
[TBL] [Abstract][Full Text] [Related]
30. The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma.
Shi C; Li X; Wang X; Ding N; Ping L; Shi Y; Mi L; Lai Y; Song Y; Zhu J
J Hematol Oncol; 2018 Mar; 11(1):43. PubMed ID: 29554921
[TBL] [Abstract][Full Text] [Related]
31. Mantle cell lymphoma: transcriptional regulation by microRNAs.
Di Lisio L; Gómez-López G; Sánchez-Beato M; Gómez-Abad C; Rodríguez ME; Villuendas R; Ferreira BI; Carro A; Rico D; Mollejo M; Martínez MA; Menárguez J; Díaz-Alderete A; Gil J; Cigudosa JC; Pisano DG; Piris MA; Martínez N
Leukemia; 2010 Jul; 24(7):1335-42. PubMed ID: 20485376
[TBL] [Abstract][Full Text] [Related]
32. A Novel Aziridine-based Bruton's Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma.
Romanchikova N; Strods A; Strazdina J; Strumfs B; Trapencieris P
Anticancer Res; 2016 Nov; 36(11):6133-6140. PubMed ID: 27793942
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
[TBL] [Abstract][Full Text] [Related]
34. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.
Vogt N; Abramov D; Koch K; Masqué-Soler N; Szczepanowski M; Klapper W
Leuk Lymphoma; 2015 Jul; 56(7):2134-40. PubMed ID: 25315075
[TBL] [Abstract][Full Text] [Related]
35. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
[TBL] [Abstract][Full Text] [Related]
36. The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma.
Ferreira GA; Thomé CH; Simão AMS; Scheucher PS; Silva CLA; Chahud F; Ciancaglini P; Leopoldino AM; Rego EM; Faça VM; Dos Santos GA
Leuk Lymphoma; 2019 Nov; 60(11):2658-2668. PubMed ID: 31060403
[TBL] [Abstract][Full Text] [Related]
37. The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells.
Lu K; Chen N; Zhou XX; Ge XL; Feng LL; Li PP; Li XY; Geng LY; Wang X
Biochem Biophys Res Commun; 2015 Aug; 464(1):292-8. PubMed ID: 26116769
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma.
Bernard S; Danglade D; Gardano L; Laguillier C; Lazarian G; Roger C; Thieblemont C; Marzec J; Gribben J; Cymbalista F; Varin-Blank N; Ledoux D; Baran-Marszak F
Int J Cancer; 2015 Jun; 136(12):2761-74. PubMed ID: 25388373
[TBL] [Abstract][Full Text] [Related]
39. Characteristic expression of Hck in human B-cell precursors.
Taguchi T; Kiyokawa N; Sato N; Saito M; Fujimoto J
Exp Hematol; 2000 Jan; 28(1):55-64. PubMed ID: 10658677
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]